SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-20-016890
Filing Date
2020-08-28
Accepted
2020-08-28 13:59:48
Documents
2
Period of Report
2020-08-27

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1634
2 ex24.htm EX-24 10979
  Complete submission text file 0001493152-20-016890.txt   14047
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Issuer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1440 VALLE GRANDE ESCONDIDO CA 92025
Business Address
BROIDRICK AMY S. (Reporting) CIK: 0001822917 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37428 | Film No.: 201147028